Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer

Oncology

Volumn 57, Issue 2, 1999, Pages 143-148

  Sunaga, Noriaki ^a,b   Tsuchiya, Satoshi ^a   Minato, Koichi ^b   Watanabe, Satoru ^a   Fueki, Naoto ^b   Hoshino, Hideki ^b   Makimoto, Takeyuki ^a   Ishihara, Shinichi ^a   Saito, Ryusei ^a   Mori, Masatomo ^b  

^a Shibukawa Medical Center   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Pro gastrin releasing peptide; Small cell lung cancer; Tumor marker

Indexed keywords

ENOLASE; GASTRIN RELEASING PEPTIDE; PROGASTRIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0032818438     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012022     Document Type: Article

References (27)

1. Carney DN, Marangos PJ, Ihde DC, Bunn PA, Cohen MH, Minna JD, Gazdar AF: Serum neuron-specific enolase: A marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1982;i:583-585.
2. Ariyoshi Y, Kato K, Ishiguro Y, Ota K, Sato T, Suchi T: Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung. Gann 1983;74:219-225.
3. Cooper EH, Splinter TAW, Brown DA, Muers MF, Peake MD, Pearson SL: Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer 1985;52: 333-338.
4. Akoun GM, Scarna HM, Milleron BJ, Benichou MP, Herman DP: Serum neuron-specific enolase: A marker for disease extent and response to therapy for small-cell lung cancer. Chest 1985;87:39-43.
5. Esscher T, Steinholtz L, Bergh J, Nou E, Nilsson K, Pahlman S: Neuron specific enolase: A useful diagnostic serum marker for small cell carcinoma of the lung. Thorax 1985;40:85-90.
6. Nou E, Steinholtz L, Bergh J, Nilsson K, Pahlman S: Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma: A prospective study in an unselected series. Cancer 1990;65:1380-1385.
7. Burghuber OC, Worofka B, Schernthaner G, Vetter N, Neumann M, Dudczak R, Kuzmits R: Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990;65:1386-1390.
8. Wharton J, Polak JM, Bloom SR, Ghatei MA, Solcia E, Brown MR, Pearse AGE: Bombesin-like immunoreactivity in the lung. Nature 1978;273:769-770.
9. McDonald TJ, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V: A gastrin releasing peptide from the porcine non-antral gastric tissue. Gut 1978;19:767-774.
10. Walsh JH, Wong HC, Dockray GJ: Bombesin-like peptides in mammals. Fed Proc 1979;38: 2315-2319.
11. Knigge U, Holst JJ, Knuhtsen S, Petersen B, Krarup T, Holst-Pedersen J, Christiansen PN: Gastrin-releasing peptide: Pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men. J Clin Endocrinol Metab 1984;59:310-315.
12. Nagalla SR, Gibson BW, Tang D, Reeve JR, Spindel ER: Gastrin-releasing peptide (GRP) is not mammalian bombesin. J Biol Chem 1992; 267:6916-6922.
13. Moody TW, Pert CB, Gazdar AF, Camey DN, Minna JD: High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 1981;214:1246-1248.
14. Yamaguchi K, Abe K, Kameya T, Adachi I, Taguchi S, Otsubo K, Yanaihara N: Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res 1983;43:3932-3939.
15. Yamaguchi K, Abe K, Adachi I, Kumura S, Suzuki M, Shimada A, Kodama T, Kameya T, Shimosato Y: Peptide hormone production in primary lung tumors. Recent Results Cancer Res 1985;99:107-116.
16. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985;316:823-826.
17. Maruno K, Yamaguchi K, Abe K, Suzuki M, Saijo N, Mishima Y, Yanaihara N, Shimosato Y: Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1989;49: 629-632.
18. Miyake Y, Kodama T, Yamaguchi K: Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994;54:2136-2140.
19. Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K: Enzyme immunoassay of immunoreactive progastrin-releasing peptide (31-98) as tumor marker for small-cell lung carcinoma: Development and evaluation. Clin Chem 1995;41:537-543.
20. Yamaguchi K, Aoyagi K, Urakami K, Fukutani T, Maki N, Yamamoto S, Otsubo K, Miyake Y, Kodama T: Enzyme-linked immunosorbent Assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement. Jpn J Cancer Res 1995;86:698-705.
21. Takada M, Kusunoki Y, Masuda N, Matsui K, Yana T, Ushijima S, Iida K, Tamura K, Komiya T, Kawase I, Kikui N, Morino H, Fukuoka M: Pro-gastrin-releasing peptide (31-98) as a tumor marker of small-cell lung cancer: Comparative evaluation with neuron-specific enolase. Br J Cancer 1996;73:1227-1232.
22. Okusaka T, Eguchi K, Kasai T, Kurata T, Yamamoto N, Ohe Y, Tamura T, Shinkai T, Saijo N: Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer. Clin Cancer Res 1997;3:123-127.
23. Stahel RA, Ginsberg R, Havemann K, Hirsch FR, Ihde DC, Jassem J, Karrer K, Maurer LH, Osterlind K, Houtte PV: Staging and prognostic factors in small cell lung cancer: A consensus report. Lung Cancer 1989;5:119-126.
24. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214.
25. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Ass 1958;53:457-481.
27. Cox DR: Regression models and life tables. J R Stat Soc B 1972;34:187-220.